HSD17B2 and breast cancer: In addition, the few studies other than BPC3 that have investigated polymorphisms in CYP2C9 [51], CYP3A4 [49,51,56], HSD17B2 [58], SRD5A1 [56], and UGT2B7 [51], in relation to breast cancer risk among Caucasian populations, have reported no associations.